Vulvar carcinoma
MONDO:0005215A carcinoma that arises from epithelial cells of the mammalian vulva
Also known as: cancer of the vulva, cancer of vulva, vulva cancer, vulvar cancer, carcinoma of mammalian vulva, carcinoma of the vulva, carcinoma of vulva, mammalian vulva carcinoma
2879 clinical trials for this condition and its sub-types, 24 tagged with Vulvar carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Vulvar carcinoma
-
Vulvar squamous cell carcinoma 22 trials
6 sub-types
- Bartholin gland squamous cell carcinoma 0 trials Sub-types →
- Vulva verrucous carcinoma 0 trials
- Vulvar basaloid squamous cell carcinoma 0 trials
- Vulvar keratinizing squamous cell carcinoma 0 trials
- Vulvar keratoacanthoma-like carcinoma 0 trials
- Vulvar non-keratinizing squamous cell carcinoma 0 trials
-
Vulvar adenocarcinoma 3 trials · 5 incl. sub-types
7 sub-types
- Vulval Paget disease 2 trials
- Bartholin gland adenocarcinoma 0 trials Sub-types →
- Adenocarcinoma of skene gland origin 0 trials
- Vulvar apocrine adenocarcinoma 0 trials
- Vulvar clear cell hidradenocarcinoma 0 trials
- Vulvar eccrine adenocarcinoma 0 trials Sub-types →
- Vulvar sebaceous carcinoma 0 trials
-
Bartholin gland carcinoma 0 trials · 1 incl. sub-types
4 sub-types
-
Clitoral carcinoma 0 trials
-
Labia majora carcinoma 0 trials
-
Labia minora carcinoma 0 trials
-
Vulva basal cell carcinoma 0 trials
-
Vulvar neuroendocrine carcinoma 0 trials
1 sub-type
- Bartholin gland small cell carcinoma 0 trials
-
Vulvar seborrheic keratosis 0 trials
1 sub-type
- Vulvar inverted follicular keratosis 0 trials
Most studied deeper sub-types
-
Immunotherapy duo takes on rare tumors
Disease control OngoingThis phase 2 trial is testing a combination of two immunotherapy drugs, nivolumab and ipilimumab, in 798 people with over 50 types of rare cancers. The goal is to see if these drugs can shrink tumors by helping the immune system attack cancer cells. Participants receive the drugs…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Keytruda takes on 15 advanced cancers in major trial
Disease control OngoingThis phase 2 trial tests the immunotherapy drug pembrolizumab (Keytruda) in people with 15 types of advanced solid tumors that have worsened after standard treatments. About 1,600 participants receive the drug to see if their tumors shrink or stop growing. The study also looks fo…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New app helps women with advanced cancer fight fear
Symptom relief OngoingThis study tests an online program called Day by Day for women with stage III or IV gynecologic cancer who have high fear of their cancer getting worse or coming back. The program teaches skills to manage anxiety and reframe worries. About 23 women will try the program for 12 wee…
Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Can we predict who recovers best from radical cancer surgery?
Knowledge-focused OngoingThis study follows women who have had pelvic exenteration—a surgery removing the lower colon, rectum, and bladder—for gynecologic cancers like cervical or endometrial cancer. Researchers want to see if factors like tumor size or surgery type affect complications, quality of life,…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Blood test may help cancer patients avoid nerve damage from chemo
Knowledge-focused PausedThis pilot study aims to see if doctors can consistently measure paclitaxel levels in the blood of cancer patients receiving the drug. The goal is to eventually adjust doses to give enough chemo to fight cancer while reducing the common side effect of nerve damage. The study invo…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
New study tracks pelvic changes after radiation in women with pelvic cancer
Knowledge-focused OngoingThis study follows 72 women with pelvic cancers (anal, cervical, endometrial, rectal, vaginal, or vulvar) who are receiving radiation therapy. Researchers will use pelvic exams and surveys to measure changes in vaginal health, sexual function, and quality of life over two years. …
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Virtual therapy trial for cancer fear pulled before starting
Knowledge-focused CancelledThis trial was designed to test whether an online mental health program could help women with advanced gynecologic or breast cancer manage their fear of the cancer returning or getting worse. The study planned to compare the online program to standard educational materials. Howev…
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC